Skip to main navigation Skip to main content
  • KSPTM
  • E-Submission

PHD : Parasites, Hosts and Diseases

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

2
results for

"antimalarial drug"

Article category

Keywords

Publication year

Authors

Funded articles

"antimalarial drug"

Original Articles
In Vitro Evaluation of Two Novel Antimalarial Derivatives of SKM13: SKM13-MeO and SKM13-F
Thuy-Tien Thi Trinh, Young-ah Kim, Hyelee Hong, Linh Thi Thuy Le, Hayoung Jang, Soon-Ai Kim, Hyun Park, Hak Sung Kim, Seon-Ju Yeo
Korean J Parasitol 2022;60(6):401-407.
Published online December 22, 2022
DOI: https://doi.org/10.3347/kjp.2022.60.6.401
Antimalarial drugs play an important role in the control and treatment of malaria, a deadly disease caused by the protozoan parasite Plasmodium spp. The development of novel antimalarial agents effective against drug-resistant malarial parasites is urgently needed. The novel derivatives, SKM13-MeO and SKM13-F, were designed based on an SKM13 template by replacing the phenyl group with electron-donating (-OMe) or electron-withdrawing groups (-F), respectively, to reverse the electron density. A colorimetric assay was used to quantify cytotoxicity, and in vitro inhibition assays were performed on 3 different blood stages (ring, trophozoite, and schizonts) of P. falciparum 3D7 and the ring/mixed stage of D6 strain after synchronization. The in vitro cytotoxicity analysis showed that 2 new SKM13 derivatives reduced the cytotoxicity of the SKM13 template. SKM13 maintained the IC50 at the ring and trophozoite stages but not at the schizont stage. The IC50 values for both the trophozoite stage of P. falciparum 3D7 and ring/mixed stages of D6 demonstrated that 2 SKM13 derivatives had decreased antimalarial efficacy, particularly for the SKM13-F derivative. SKM13 may be comparably effective in ring and trophozoite, and electron-donating groups (-OMe) may be better maintain the antimalarial activity than electron-withdrawing groups (-F) in SKM13 modification.

Citations

Citations to this article as recorded by  Crossref logo
  • Design, Synthesis and in vitro Evaluation of Primaquine and Diaminoquinazoline Hybrid Molecules Against the Malaria Parasite
    Mukul Kore, Anjani G. Rao, Dimple Acharya, Shrikant S. Kirwale, Amritansh Bhanot, Abhishek Govekar, Ajeet Kumar Mohanty, Aniruddha Roy, Shruthi S. Vembar, Sandeep Sundriyal
    Chemistry – An Asian Journal.2025;[Epub]     CrossRef
  • Evaluation of the antimalarial activity of SAM13-2HCl with morpholine amide (SKM13 derivative) against antimalarial drug-resistant Plasmodium falciparum and Plasmodium berghei infected ICR mice
    Hyelee Hong, Kwonmo Moon, Thuy-Tien Thi Trinh, Tae-Hui Eom, Hyun Park, Hak Sung Kim, Seon-Ju Yeo
    Parasites, Hosts and Diseases.2024; 62(1): 42.     CrossRef
  • 3,323 View
  • 140 Download
  • 2 Web of Science
  • Crossref
Aspartic proteases of Plasmodium vivax are highly conserved in wild isolates
Byoung-Kuk Na, Eung-Goo Lee, Hyeong-Woo Lee, Shin-Hyeong Cho, Young-An Bae, Yoon Kong, Jong-Koo Lee, Tong-Soo Kim
Korean J Parasitol 2004;42(2):61-66.
Published online June 20, 2004
DOI: https://doi.org/10.3347/kjp.2004.42.2.61

The plasmepsins are the aspartic proteases of malaria parasites. Treatment of aspartic protease inhibitor inhibits hemoglobin hydrolysis and blocks the parasite development in vitro suggesting that these proteases might be exploited their potentials as antimalarial drug targets. In this study, we determined the genetic variations of the aspartic proteases of Plasmodium vivax (PvPMs) of wild isolates. Two plasmepsins (PvPM4 and PvPM5) were cloned and sequenced from 20 P. vivax Korean isolates and two imported isolates. The sequences of the enzymes were highly conserved except a small number of amino acid substitutions did not modify key residues for the function or the structure of the enzymes. The high sequence conservations between the plasmepsins from the isolates support the notion that the enzymes could be reliable targets for new antimalarial chemotherapeutics.

Citations

Citations to this article as recorded by  Crossref logo
  • The Effect of Aqueous Extract of Cinnamon on the Metabolome ofPlasmodium falciparumUsing1HNMR Spectroscopy
    Shirin Parvazi, Sedigheh Sadeghi, Mehri Azadi, Maryam Mohammadi, Mohammad Arjmand, Farideh Vahabi, Somye Sadeghzadeh, Zahra Zamani
    Journal of Tropical Medicine.2016; 2016: 1.     CrossRef
  • Use of multiplex real-time PCR for detection of common diarrhea causing protozoan parasites in Egypt
    John T. Nazeer, Khalifa El Sayed Khalifa, Heidrun von Thien, Mahmoud Mohamed El-Sibaei, Magda Youssef Abdel-Hamid, Ranya Ayman Samir Tawfik, Egbert Tannich
    Parasitology Research.2013; 112(2): 595.     CrossRef
  • Imperfect Duplicate Insertions Type of Mutations in Plasmepsin V Modulates Binding Properties of PEXEL Motifs of Export Proteins in Indian Plasmodium vivax
    Manmeet Rawat, Sonam Vijay, Yash Gupta, Pramod Kumar Tiwari, Arun Sharma, Rajvir Dahiya
    PLoS ONE.2013; 8(3): e60077.     CrossRef
  • Sequence homology and structural analysis of plasmepsin 4 isolated from Indian Plasmodium vivax isolates
    Manmeet Rawat, Sonam Vijay, Yash Gupta, Rajnikant Dixit, P.K. Tiwari, Arun Sharma
    Infection, Genetics and Evolution.2011; 11(5): 924.     CrossRef
  • Single nucleotide polymorphisms, putatively neutral DNA markers and population genetic parameters in IndianPlasmodium vivaxisolates
    BHAVNA GUPTA, ADITYA P. DASH, NALINI SHRIVASTAVA, APARUP DAS
    Parasitology.2010; 137(12): 1721.     CrossRef
  • Characterization of plasmepsin V, a membrane-bound aspartic protease homolog in the endoplasmic reticulum of Plasmodium falciparum
    Michael Klemba, Daniel E. Goldberg
    Molecular and Biochemical Parasitology.2005; 143(2): 183.     CrossRef
  • Purification and Characterization of a Hemoglobin Degrading Aspartic Protease from the Malarial Parasite Plasmodium vivax
    Arun Sharma, Alex Eapen, Sarala K. Subbarao
    The Journal of Biochemistry.2005; 138(1): 71.     CrossRef
  • 8,721 View
  • 69 Download
  • Crossref